HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer.

Abstract
Hepcidin is a peptide hormone that negatively regulates iron efflux and plays an important role in controlling the growth of breast tumors. In patients with breast cancer, the combined expression of hepcidin and its membrane target, ferroportin, predict disease outcome. However, mechanisms that control hepcidin expression in breast cancer cells remain largely unknown. Here, we use three-dimensional breast cancer spheroids derived from cell lines and breast cancer patients to probe mechanisms of hepcidin regulation in breast cancer. We observe that the extent of hepcidin induction and pathways of its regulation are markedly changed in breast cancer cells grown in three dimensions. In monolayer culture, BMPs, particularly BMP6, regulate hepcidin transcription. When breast cancer cells are grown as spheroids, there is a >10-fold induction in hepcidin transcripts. Microarray analysis combined with knockdown experiments reveal that GDF-15 is the primary mediator of this change. The increase in hepcidin as breast cells develop a three-dimensional architecture increases intracellular iron, as indicated by an increase in the iron storage protein ferritin. Immunohistochemical staining of human breast tumors confirms that both GDF-15 and hepcidin are expressed in breast cancer specimens. Further, levels of GDF-15 are significantly correlated with levels of hepcidin at both the mRNA and protein level in patient samples, consistent with a role for GDF-15 in control of hepcidin in human breast tumors. Inclusion of tumor-associated fibroblasts in breast cancer spheroids further induces hepcidin. This induction is mediated by fibroblast-dependent secretion of IL-6. Breast cancer cells grown as spheroids are uniquely receptive to IL-6-dependent induction of hepcidin by tumor-associated fibroblasts, since IL-6 does not induce hepcidin in cells grown as monolayers. Collectively, our results suggest a new paradigm for tumor-mediated control of iron through the control of hepcidin by tumor architecture and the breast tumor microenvironment.
AuthorsNicole Blanchette-Farra, Daniel Kita, Anna Konstorum, Lia Tesfay, David Lemler, Poornima Hegde, Kevin P Claffey, Frank M Torti, Suzy V Torti
JournalOncogene (Oncogene) Vol. 37 Issue 29 Pg. 4013-4032 (07 2018) ISSN: 1476-5594 [Electronic] England
PMID29695834 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Growth Differentiation Factor 15
  • Hepcidins
  • Interleukin-6
  • RNA, Messenger
Topics
  • Aged
  • Aged, 80 and over
  • Animals
  • Breast Neoplasms (metabolism, pathology)
  • Cancer-Associated Fibroblasts (metabolism, pathology)
  • Cell Line
  • Cell Line, Tumor
  • Cell Proliferation (physiology)
  • Female
  • Growth Differentiation Factor 15 (metabolism)
  • Hepcidins (metabolism)
  • Humans
  • Interleukin-6 (metabolism)
  • MCF-7 Cells
  • Mice
  • Middle Aged
  • NIH 3T3 Cells
  • RNA, Messenger (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: